Craig Kevin James 4
4 · AtaiBeckley Inc. · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
AtaiBeckley (ATAI) CMO Craig James Sells 100,000 Shares, Exercises Options
What Happened
Craig Kevin James, Chief Medical Officer of AtaiBeckley Inc. (ATAI), exercised stock options to acquire a total of 100,000 shares (76,224 shares at $1.18 and 23,776 shares at $1.50) for a total cash exercise cost of $125,608. On the same day (Mar 20, 2026) he sold 100,000 shares in the open market for aggregate gross proceeds of $355,000 (weighted average price reported as $3.55; individual sale prices ranged $3.52–$3.60). The Form 4 also reports the corresponding derivative interests (the exercised options) as disposed (reported at $0).
Key Details
- Transaction date: March 20, 2026; Form 4 filed March 24, 2026 (filed within the two-business-day requirement).
- Option exercises acquired: 76,224 shares @ $1.18 = $89,944 and 23,776 shares @ $1.50 = $35,664 (total cash paid $125,608).
- Open-market sale: 100,000 shares @ weighted avg $3.55 = $355,000 (sales ranged $3.52–$3.60). Reporting person can provide exact breakdown per price on request (footnote).
- Shares owned after transaction: Not specified in the filing.
- Notable footnotes: Transactions were carried out pursuant to a Rule 10b5-1 trading plan adopted Dec 19, 2025 (F1). Vesting schedules for the options are noted (25% cliff then monthly vesting over 36 months) (F2, F3). Sale price is a weighted average; full per-price breakdown available on request (F4).
- Transaction codes: M = exercise/conversion of derivative (options); S = sale.
Context
- The filing shows options were exercised and an equal number of shares were sold the same day, indicating the exercised shares were not retained. This is commonly executed as a cashless exercise/sale pattern, but the filing itself only reports the mechanical steps (exercise and sale).
- The trades were made under a pre-established 10b5-1 plan, which is designed to allow insiders to sell shares according to a preset schedule and can reduce concerns about timing-based insider trading.
- These entries are factual disclosures of insider activity and do not by themselves indicate the insider’s view on the company’s prospects.
Insider Transaction Report
Form 4
AtaiBeckley Inc.ATAI
Craig Kevin James
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-20$1.18/sh+76,224$89,944→ 84,661 total - Exercise/Conversion
Common Stock
[F1]2026-03-20$1.50/sh+23,776$35,664→ 108,437 total - Sale
Common Stock
[F1][F2]2026-03-20$3.55/sh−100,000$355,000→ 8,437 total - Exercise/Conversion
Stock Option
[F3]2026-03-20−76,224→ 38,136 totalExercise: $1.18Exp: 2033-03-14→ Common Stock (76,224 underlying) - Exercise/Conversion
Stock Option
[F4]2026-03-20−23,776→ 734,139 totalExercise: $1.50Exp: 2035-03-03→ Common Stock (23,776 underlying)
Footnotes (4)
- [F1]The option exercises and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
- [F2]The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter.
- [F3]The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
- [F4]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.52 to $3.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Signature
/s/ Ryan Barrett, as attorney in fact|2026-03-24